All performed autoantibody tests for autoimmune rheumatic disorders, including myositis-specific antibodies (anti-Jo-1), as well as myositis-associated antibodies (anti-U1-RNP, anti-Ro52, anti-SSB and anti-PM-Scl) were negative. Here, TRIM21 is linked to myositis disease.